Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
FEMASYS INC
| Metric | FEMASYS INC FEMYHealthcare |
|---|---|
| Quality Score | 43 / 100 |
| Revenue (latest) | $2M |
| Net income (latest) | −$19M |
| Operating margin | −767.0% |
| Net margin | −812.3% |
| Return on equity | −317.4% |
| Return on assets | −89.9% |
| Return on capital (ROCE) | −102.9% |
| Debt / equity | 2.53× |
| Revenue growth (YoY) | 40.8% |
| Altman Z″ (distress) | -24.17 |
| Accruals / assets | 0.3% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.